Health
CRISPR Screen Identifies Mitochondrial Enzyme Target for Anti-inflammatory Therapeutics – Clinical OMICs News
The MTHFD2 enzyme could be an important new drug target for inflammatory diseases such as multiple sclerosis and inflammatory…
A study led by researchers at Vanderbilt University Medical Center has identified a potential new drug target to treat inflammatory conditions such as multiple sclerosis, inflammatory bowel disease, and allergies, a mitochondrial enzyme encoded by the gene…
Continue Reading
